Browsing Tag
psychedelic drug development
2 posts
Why Enveric Biosciences (NASDAQ: ENVB) may still be overlooked despite PTSD trial progress
Enveric stock dips despite FDA and PTSD progress on EB-003. Find out why investors are cautious and what milestones could restore confidence.
Atai Life Sciences acquires exclusive rights to Psilera’s DMT patent portfolio
Atai Life Sciences has taken a strategic step in expanding its position in psychedelic medicine by securing exclusive…